Here's how to give your cap a #Halloween makeover with pumpkin patterned napkin and some #modpodge... 🎃 #decoupage ...

High-quality dividend stocks like OKE, PFE, and CAG gain as low rates and OKE's 5.6% yield drive upside. Find out why SCHD ...

The BMS-Pfizer alliance has dominated the anticoagulant drug market, earning approximately $82.6bn in revenue since 2011.

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

Explore SPYV: a large-cap value S&P 500 ETF with diversified sectors, a 16% P/E discount, and lower volatility. Read the full ...

Startups and enterprises can complement each other by collaborating. Learn how large and small players can overcome issues and work together.

Pfizer Inc. (NYSE: PFE) disclosed the death of a participant in a long-term open-label extension study of marstacimab in patients with hemophilia A or B. In October 2024, the FDA approved Pfizer’s ...

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several hemophilia advocacy groups confirmed this week. Pfizer is now working with its ...

A robocall scam is targeting hundreds of thousands of consumers each week, with fraudsters impersonating employees of Walmart in an effort to obtain people's personal information, according to a ...

Pfizer Inc. forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions. Revenue in 2026 will be $59.5 ...

The allegations were made in an FTC lawsuit, dropped in May by the Trump administration, that was recently unsealed. Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings Pfizer ...